Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients

Ja Perini, Claúdio J. Struchiner, E Silva-Assunção, Iris Layane Santos Santana, Fj Rangel, Eb Ojopi, Emmanuel Dias‐Neto, Guilherme Suarez‐KurtzClinical 2008 · DOI

Abstract

A dosing algorithm including genetic (VKORC1 and CYP2C9 genotypes) and nongenetic factors (age, weight, therapeutic indication, and cotreatment with amiodarone or simvastatin) explained 51% of the variance in stable weekly warfarin doses in 390 patients attending an anticoagulant clinic in a Brazilian public hospital. The VKORC1 3673G>A genotype was the most important predictor of warfarin dose, with a partial R(2) value of 23.9%. Replacing the VKORC1 3673G>A genotype with VKORC1 diplotype did not increase the algorithm's predictive power. We suggest that three other single-nucleotide polymorphisms (SNPs) (5808T>G, 6853G>C, and 9041G>A) that are in strong linkage disequilibrium (LD) with 3673G>A would be equally good predictors of the warfarin dose requirement. The algorithm's predictive power was similar across the self-identified "race/color" subsets. "Race/color" was not associated with stable warfarin dose in the multiple regression model, although the required warfarin dose was significantly lower (P = 0.006) in white (29 +/- 13 mg/week, n = 196) than in black patients (35 +/- 15 mg/week, n = 76).
BibTeX
@inproceedings{perini2008pharmacogenetics,
  author = {JA Perini and Claúdio J. Struchiner and E Silva-Assunção and Iris Layane Santos Santana and FJ Rangel and EB Ojopi and Emmanuel Dias‐Neto and Guilherme Suarez‐Kurtz},
  title = {{Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients}},
  booktitle = {Clinical},
  year = {2008},
  doi = {10.1038/clpt.2008.166},
}

Loading related content...

Figure